{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:03:42Z","timestamp":1789380222336,"version":"build-2803163510"},"reference-count":36,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T00:00:00Z","timestamp":1168214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many reproductive factors are associated with breast cancer risk, potentially through a hormonal pathway. The peptide hormone prolactin is essential in mammary development and lactation and may be a link between risk factors and breast cancer. While higher prolactin levels are associated with increased breast cancer risk, few determinants of prolactin levels are known. We conducted a cross\u2010sectional analysis among 1,089 premenopausal and 1,311 postmenopausal women within the Nurses' Health Study (NHS) and the NHS II to examine the associations of reproductive factors, benign breast disease and family history of breast cancer with plasma prolactin levels. Parous women had significantly lower prolactin levels than nulliparous women (parous <jats:italic>vs.<\/jats:italic> nulliparous multivariate\u2010adjusted geometric means = 14.1 ng\/mL <jats:italic>vs.<\/jats:italic> 16.6 ng\/mL, <jats:italic>p<\/jats:italic> &lt; 0.001 for premenopausal and 9.1 <jats:italic>vs.<\/jats:italic> 10.1, <jats:italic>p<\/jats:italic> = 0.04 for postmenopausal women), although levels did not decrease with increasing number of children for either premenopausal (<jats:italic>p<\/jats:italic>\u2010trend = 0.23) or postmenopausal (<jats:italic>p<\/jats:italic>\u2010trend = 0.07) parous women. Age at first birth was not associated with prolactin levels. The reduction in prolactin levels among parous premenopausal women appeared to attenuate with increasing time since first birth, but the trend was not statistically significant (<jats:italic>p<\/jats:italic>\u2010trend = 0.12). Age at menarche, duration of lactation and benign breast disease were not associated with prolactin levels. Family history of breast cancer was associated with significantly higher prolactin levels when compared with no family history among premenopausal (15.9 ng\/mL <jats:italic>vs.<\/jats:italic> 14.3 ng\/mL, <jats:italic>p<\/jats:italic> = 0.04) but not postmenopausal (<jats:italic>p<\/jats:italic> = 0.73) women. In conclusion, the associations of parity and family history with breast cancer risk may be mediated, at least in part, by prolactin levels. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.22482","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T18:47:44Z","timestamp":1168282064000},"page":"1536-1541","source":"Crossref","is-referenced-by-count":54,"title":["Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women"],"prefix":"10.1002","volume":"120","author":[{"given":"A. Heather","family":"Eliassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,30]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015714305420"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3369"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1870"},{"key":"e_1_2_6_5_2","first-page":"575","article-title":"A prospective study of estradiol and breast cancer in Japanese women","volume":"9","author":"Kabuto M","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.2.214"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025671317220"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0036"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.4.1523"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1990.tb126153.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910915)68:6<1401::AID-CNCR2820680637>3.0.CO;2-K"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198701293160501"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90098-8"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1981.121"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90132-0"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910440506"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00051793"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.17.1297"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/clinchem\/35.12.2313","article-title":"Effect of transport conditions on the stability of biochemical markers in blood","volume":"35","author":"Hankinson SE","year":"1989","journal-title":"Clin Chem"},{"key":"e_1_2_6_20_2","first-page":"649","article-title":"Reproducibility of plasma hormone levels in postmenopausal women over a 2\u20133\u2010year period","volume":"4","author":"Hankinson SE","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0848"},{"key":"e_1_2_6_22_2","first-page":"71","article-title":"Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting","volume":"76","author":"Fujimoto VY","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1983.10487848"},{"key":"e_1_2_6_24_2","volume-title":"Yen and Jaffe's reproductive endocrinology","author":"Strauss JF","year":"2004"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-6-1111"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0015-0282(16)54293-9","article-title":"Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle","volume":"55","author":"Espinosa de los Monteros A","year":"1991","journal-title":"Fertil Steril"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2005.03.006"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0917"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/152.10.950"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.1999.9271"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480070057030"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114995"},{"key":"e_1_2_6_33_2","first-page":"695","article-title":"Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine\/paracrine loop","volume":"146","author":"Clevenger CV","year":"1995","journal-title":"Am J Pathol"},{"key":"e_1_2_6_34_2","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet2001;358:1389\u201399.","DOI":"10.1016\/S0140-6736(01)06524-2"},{"key":"e_1_2_6_35_2","first-page":"4006","article-title":"Plasma hormone profiles of young women at risk for familial breast cancer","volume":"38","author":"Fishman J","year":"1978","journal-title":"Cancer Res"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-1-179"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-2-379"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.22482","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.22482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T01:01:25Z","timestamp":1697245285000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.22482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,30]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1002\/ijc.22482"],"URL":"https:\/\/doi.org\/10.1002\/ijc.22482","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,30]]}}}